SBIRT for Pain Management in Substance Use Disorders
Trial Summary
What is the purpose of this trial?
Veterans seeking compensation for musculoskeletal (MSD) conditions often develop chronic pain and are at high risk for substance misuse. The Investigators propose to test the effectiveness and cost-effectiveness of Screening, Brief Intervention and Referral to Treatment for Pain Management (SBIRT-PM), designed to reduce pain and reduce risky substance use, in part by helping Veterans get comprehensive pain treatment. The study will involve clinicians at a single site contacting Veterans throughout New England by phone to deliver SBIRT-PM counseling in a pragmatic, randomized, clinical trial.
Research Team
Marc Rosen, MD
Principal Investigator
Yale University/ VA Connecticut Healthcare System
Steve Martino, PhD
Principal Investigator
Yale University/ VA Connecticut Healthcare System
Eligibility Criteria
This trial is for post-9/11 veterans who are applying for compensation due to musculoskeletal conditions, have moderate to severe pain (scoring ≥4 on a pain scale), and own a phone. It's not open to those unable or unwilling to participate, those already receiving multiple non-drug pain treatments from the VA, or participants in another related study.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- SBIRT-PM
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
US Department of Veterans Affairs
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator